Business Description
Enanta Pharmaceuticals is a Massachusetts-based biotech company focused on creating small molecule treatments for viral infections and immune system disorders. Its drug pipeline covers a range of conditions, including hepatitis B and C, respiratory syncytial virus, COVID-19-related coronaviruses, chronic hives, and atopic dermatitis. The company works alongside Abbott Laboratories under a licensing agreement to develop and bring to market several hepatitis C treatments. Founded in 1995, Enanta continues to advance multiple therapies through various stages of clinical testing.
